You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

Perrigo Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for PERRIGO, and what generic and branded alternatives to PERRIGO drugs are available?

PERRIGO has one hundred and twelve approved drugs.

There are three tentative approvals on PERRIGO drugs.

Summary for Perrigo

US Patents:	0
Tradenames:	65
Ingredients:	55
NDAs:	112
Patent Litigation for Perrigo:	See patent lawsuits for Perrigo
PTAB Cases with Perrigo as petitioner:	See PTAB cases with Perrigo as petitioner

Drugs and US Patents for Perrigo

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Perrigo R And D	GUAIFENESIN	guaifenesin	TABLET, EXTENDED RELEASE;ORAL	078912-002	Nov 5, 2020		OTC	No	No		⤷ Subscribe				⤷ Subscribe
Perrigo Pharma Intl	LORATADINE AND PSEUDOEPHEDRINE SULFATE	loratadine; pseudoephedrine sulfate	TABLET, EXTENDED RELEASE;ORAL	076050-001	Jan 30, 2003		OTC	No	No		⤷ Subscribe				⤷ Subscribe
Perrigo R And D	LOPERAMIDE HYDROCHLORIDE	loperamide hydrochloride	SUSPENSION;ORAL	091292-001	May 20, 2011		OTC	No	No		⤷ Subscribe				⤷ Subscribe
Perrigo New York	BETAMETHASONE DIPROPIONATE	betamethasone dipropionate	OINTMENT;TOPICAL	072526-001	Jan 31, 1990		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.